Authors
Latest:
Healthcare Utilization and Costs for Insured Patients With FibromyalgiaFibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.
Latest:
What Pharmacy Students Need to Know about MTMMedication therapy management has become an important buzzword in the world of pharmacy.
Latest:
Manufacturers Launch Programs to Allow Greater Access to Insulin in Response to COVID-19In response to the financial crisis driven by the coronavirus disease 2019 (COVID-19) pandemic, drug manufacturers are aiming to increase access to insulin products.
Latest:
Patient Adherence: Identifying Barriers and Defining SolutionsMajor patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.
Latest:
Oral Oncology: Utilization of Selected Oral Antineoplastic Enzyme Inhibitor AgentsAn overview of the utilization and cost for selected oral antineoplastic agents, with discussion regarding oncology in general, as well as the topic of adherence.
Latest:
Giapreza: A Look at the Pharmacology of Ang2Angiotensin-II is the newest vasopressor available on the market.
Latest:
What are the Implications of Transparency Legislation on Specialty Pharmacy?Ron Lanton III, Esq, president of True North Political Solutions, LLC, discusses how recently proposed transparency legislation may affect specialty pharmacies.
Latest:
Responding Proactively to Antikickback GuidelinesThe time has come to be proactive in finding a path that can benefit all potential stakeholders, rather than letting other third parties define the system in a way that negatively affects potential outcomes.
Latest:
"Here Us Now:" The Patient Community Has SpokenA new documentary has been released that underscores the need for accelerating alternative pathways for new discoveries that hold the promise for curing patients.
Latest:
OTC Focus Case Studies: CancerProstate cancer prevention, irinotecan-induced diarrhea, smoking cessation, and more.
Latest:
Cost and Utilization Outcomes Associated With a Dosage Consolidation and Quantity Limits ProgramDose consolidation and quantity limit initiatives decreased utilization and cost outcomes for select mental health drugs in a fee-for-service Medicaid environment.
Latest:
Novel Tactics: Deterring Opioid AbuseSince the introduction of the new formulation of OxyContin, drug makers have sought innovative ways to curb the abuse of painkillers.
Latest:
Prescription Utilization of the Oral AnticoagulantsNew and forthcoming oral anticoagulants, which do not require prothrombin time monitoring, will offer patients and providers additional therapeutic options.
Latest:
A Computerized Asthma Outcomes Measure Is Feasible for Disease ManagementThe ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.
Latest:
The Greatest ProfessionTouted by U.S. News & World Report as a top career for 2009, pharmacy offers unique opportunities for growth and professional fulfillment.
Latest:
Going Against the Flow: Treating Overactive BladderThe impact of overactive bladder on quality of life is a major concern and pharmacists can help patients with this common condition.
Latest:
A Review of DupilumabDupixent is the first FDA-approved medicine for adults with chronic rhinosinusitis with nasal polyposis and the only approved therapy shown to shrink nasal polyp size and improve the signs and symptoms of the associated chronic rhinosinusitis.
Latest:
Trust Is a Potential Hole in the Emerging COVID-19 Mass Immunization StrategyPolicy makers and public health officials should not discount the importance of relationships in vaccination game plans.
Latest:
Reducing ErrorsThe human element plays a pivotal role in adapting to new technology and aiming "the silver bullet."
Latest:
Digoxin Linked to High Risk of Sudden Death in AFibPatients with atrial fibrillation (AFib) have an increased risk of death when they take digoxin, a risk that increases with dosage, a study found.
Latest:
FDA Committee Does Not Recommend Approval of Aducanumab for Alzheimer DiseaseA final vote that assessed whether the findings from the EMERGE trial served as primary evidence for the efficacy of aducanumab in Alzheimer disease was 10–0 that the trial did not provide evidence.
Latest:
The Community Pharmacist: Frontline Care Provider for VapingAs more vaping cases are reported, patients may desire answers from their trusted providers.
Latest:
Therapeutic Interchange of Carvedilol to Bisoprolol for Chronic Heart Failure: The Singapore ExperienceA carvedilol to bisoprolol interchange program was carried out in a Singapore hospital with substantial cost savings of US$116 per patient-year without increase in adverse outcomes.
